ACAAI Network Search

Here is the latest update from UnitedHealth Group. We encourage you to bookmark and check the UHG site regularly for… The Advocacy Council is aware many practices have experienced devastating fallout from the Change Healthcare cyberattack – an issue directly affecting cash flow that…

This month’s articles and reviews provide guidance for these changes in our treatment pathways.… As spring arrives and pollen season begins, the current issue of Annals of Allergy, Asthma and Immunology highlights many of the new changes that are coming to our field. As…

What does it take to bring the ACAAI Annual Scientific Meeting to life each year? Believe it or not, planning… One of the most interesting parts of being president of the College is the ability to see many things “up close and personal” that…

On February 16, 2024, the FDA announced the approval of the first biologic medication to treat patients with food allergy,… On February 16, 2024, the FDA announced the approval of the first biologic medication to treat patients with food allergy, omalizumab.…

Due to the attack, Change Healthcare's systems are still down, causing struggles for physician practices and hospitals filing claims, as… On Feb. 21,  Optum announced that its subsidiary, Change Healthcare, was the victim of a massive cyberattack. Change Healthcare is one of the largest…

In Part 2, we will discuss important considerations in implementing omalizumab for food allergy in your practice.… On February 16, 2024, the FDA announced the approval of the first biologic medication to treat patients with food allergy, omalizumab! In first part of a two-part…

In first part of a two-part series, we will review the evidence behind the Omalizumab as Monotherapy and as Adjunct… On February 16, 2024, the FDA announced the approval of the first biologic medication to treat patients with food allergy, omalizumab! In first part…

The FDA announced its approval of omalizumab as the first biologic medication to treat patients with food allergy.… As the College previously reported, on Feb. 16, the FDA announced its approval of omalizumab as the first biologic medication to treat patients with food allergy.…

Practice Parameters are developed by the Joint Taskforce on Practice Parameters and establish guidelines for diagnosis and management of allergic… Practice Parameters are developed by the Joint Taskforce on Practice Parameters and establish guidelines for diagnosis and management of allergic and immunologic diseases. Practice Parameters…

Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests. If you did not see this article with the… Artificial intelligence outperforms pulmonologists in the interpretation of pulmonary function tests. If you did not see this article with the title above, then you should…

Many third-party payers insist skin tests are a part of an office visit, but this is not the case, and… ACAAI physician members often share questions and issues on DocMatter, the College’s exclusive members-only, private forum for clinical and practice management discussions. A recent…

There is still time to be a part of the College’s House of Delegates! We’re looking for State and Super… There is still time to be a part of the College’s House of Delegates (HOD)! The HOD works closely with the College’s national Advocacy…

A survey revealed 75% of surveyed allergists were only somewhat knowledgeable about respiratory effects and allergic reactions to cannabis… The College’s new Cannabis Educational Modules educate allergists about cannabis use in patients, the rising concern of cannabis allergy, and ways to effectively discuss cannabis…

While 340B is not the most relevant federal program for allergy practices, it is helpful to have a better understanding… Created in 1992 as section 340B of the Public Health Service Act, the 340B Drug Pricing Program is an important and controversial policy intended…

Vision Forward is a “living” document that is being refined from year to year, to ensure the College stays responsive… The College’s Vision Forward plan gives us a roadmap to further elevate our profile, enhance our offerings, engage our members and educate the public…

The following are key actions taken by the ACAAI Board of Regents and Executive Committee at recent meetings.… The following are key actions taken by the ACAAI Board of Regents and Executive Committee at recent meetings. Ratified the appointment of Kathleen May, MD FACAAI…

Members of the subcommittee are social media influencers who communicate on a regular basis about allergy and asthma issues.… The Social Media Subcommittee, chaired by Farah Nawaz Khan, MD, focuses on enhancing the College’s messaging and outreach via social media channels to raise public…

If you are new to serving in a committee leadership position (or aspire to do so), you may be wondering… If you are new to serving in a committee leadership position (or aspire to do so in the future), you may be wondering how…

This is a great time of year to share your expertise with your community – through special events or media… Spring is right around the corner, and the season brings allergic conditions to the spotlight. With so much attention focused on asthma and allergies,…